Results 21 to 30 of about 6,409,647 (168)

Overview of peripheral arteriovenous malformations: From diagnosis to treatment methods

open access: yesJournal of Interventional Medicine, 2023
Based on the latest classification by the International Society for the Study of Vascular Anomalies in 2018, vascular malformations (VMs) can be categorized into simple, combined VMs of major named vessels, and VMs associated with other anomalies. Simple
Yuchen Shen   +3 more
doaj   +1 more source

Prenatal imaging phenotypes and outcomes of umbilical-portal-systemic venous shunts in singleton and twin pregnancies: A historical cohort study. [PDF]

open access: yesActa Obstet Gynecol Scand
This retrospective cohort compared umbilical‐portal‐systemic venous shunts in singleton and twin pregnancies. Type III was the most common subtype in singletons, whereas Type II was the most common in twins. Fetal growth restriction was more frequent in twins, but primary structural anomaly rates were similar.
Zhang Y   +8 more
europepmc   +2 more sources

Refractory kaposiform lymphangiomatosis relieved by splenectomy

open access: yesFrontiers in Pediatrics, 2023
IntroductionKaposiform lymphangiomatosis (KLA) is a rare and complex lymphatic anomaly with a poor prognosis. There is no standard treatment, and drug therapies are the most common therapeutic method.
Yuru Lan   +4 more
doaj   +1 more source

Kaposiform Lymphangiomatosis in a Male Adolescent: A Clinical Challenge and the Role of Genetics

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2023
Kaposiform lymphangiomatosis (KLA) is a rare and aggressive generalized lymphatic anomaly (GLA), with distinctive clinical, radiology, morphologic, and genetic features.
Joana Pereira-Nunes MD   +5 more
doaj   +1 more source

Prenatal Detection of Rapid Progressive Changes in Massive Lymphangioma from Flank to the Lower Extremity

open access: yesDiagnostics, 2023
Lymphangioma is a congenital anomaly in which abnormal lymphatic drainages localize to form a benign mass, but it has the tendency to grow in size and the potential to infiltrate surrounding structures, causing devastating effects and leading to severe ...
Saipin Pongsatha   +3 more
doaj   +1 more source

Comprehensive Analyses of Coagulation Parameters in Patients with Vascular Anomalies

open access: yesBiomolecules, 2022
Background: Vascular anomalies comprise a diverse group of rare diseases with altered blood flow and are often associated with coagulation disorders. The most common example is a localized intravascular coagulopathy in venous malformations leading to ...
Friedrich G. Kapp   +6 more
doaj   +1 more source

Lymphatic vascular morphogenesis in development, physiology, and disease [PDF]

open access: yes, 2011
The lymphatic vasculature constitutes a highly specialized part of the vascular system that is essential for the maintenance of interstitial fluid balance, uptake of dietary fat, and immune response. Recently, there has been an increased awareness of the
Amélie Sabine   +9 more
core   +2 more sources

Contrasting Cases of Complex Lymphatic Anomalies: Case Reports and Review of the Literature

open access: yesJournal of Vascular Anomalies, 2021
Complex lymphatic anomalies (CLAs) are rare, pediatric developmental lymphatic anomalies that include a spectrum of overlapping clinical presentations, imaging findings, and symptoms. Owing to their rarity, diagnosis and treatment can be challenging. CLAs have significant risk of morbidity and mortality and require multimodal, comprehensive management.
Carolyn G. Ahlers   +3 more
openaire   +2 more sources

Generalized Lymphatic Anomaly as a Differential Diagnosis of Lytic Lesions [PDF]

open access: yes, 2023
Generalized lymphatic anomaly (GLA) is an infrequent multiorgan disease characterized by the presence of abnormal proliferation of lymphatic vessels. The diagnosis requires histological confirmation, and the treatment is controversial.
María Laura Galluzzo   +23 more
core   +1 more source

Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination. [PDF]

open access: yes, 2015
Lymphatic filariasis has been targeted for elimination by 2020, and a threshold of 65% coverage of mass drug administration (MDA) has been adopted by the Global Programme to Eliminate Lymphatic Filariasis (GPELF).
Alexander, Neal DE
core   +1 more source

Home - About - Disclaimer - Privacy